Business Daily Media

Men's Weekly

.

NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3

  • Written by ACN Newswire

NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3

- Trial achieved its primary endpoint of pathological Complete Response Rate- Trial achieved its secondary endpoint in operability (R0 rate)- NBTXR3 demonstrated significant superiority and clinical benefits for patients versus standard of care- Safety profile confirmed- Randomized trial validated the first-in-class mode of action of NBTXR3Paris,...

AIIMS Group and AdVisible merge

Two of Australia’s most established independent agencies unite, creating marketing powerhouse backed by three decades of combined experience     ...

Block's layoffs are a design win. Here's why

We spend millions designing features that save users 30 seconds. Block just saved thousands of employees 40 hours a week. That's not a crisis. That's...

Why I Decided to Build a Better Way to Build Homes

Why does building a home still feel like stepping into the unknown? In an industry where costs blow out and decisions come too late, certainty has...

Leonardo.Ai reveals new brand, expanding its creator-first platform for the next era of generative AI

The company has also launched its developer API to empower creators and builders to integrate AI into their workflows SYDNEY, Australia – 19 Febr...

Psychosocial injury risk starts inside workplace microcultures

Psychological injury is now one of the most expensive categories of workers compensation claims in Australia, with Safe Work Australia reporting t...

2025 Thryv Business and Consumer Report - Australian small businesses show grit under pressure

Australia’s small businesses are powering ahead with optimism, resilience and discipline, however, mounting pressures on costs, wellbeing and cons...